当前位置: 首页 > 期刊 > 《中外医疗》 > 2017年第23期
编号:13110684
兰索拉唑联合康复新液治疗消化道溃疡的临床研究(1)
http://www.100md.com 2017年8月15日 《中外医疗》 2017年第23期
     DOI:10.16662/j.cnki.1674-0742.2017.23.150

    [摘要] 目的 对消化道溃疡患者采用兰索拉唑联合康复新液治疗的效果分析。方法 方便在该院2016年1月—2017年1月以消化道溃疡为诊断的150例患者,随机分为两组,对照组予兰索拉唑胶囊治疗2周,联合组在其基础之上加用康复新液。将两组疗效、止血时间、胃液pH、血清胃泌素水平进行对比分析。结果 联合组总有效率为94.66%优于对照组总有效率为69.34%。联合组胃液pH高且血清胃泌素水平低止血时间短于对照组,差异有统计学意义(P<0.05)。结论 对于消化道溃疡患者采用兰索拉唑联合康复新液治疗,临床效果较优,可提高胃液pH值,效果理想值得临床推广。

    [关键词] 兰索拉唑;康复新液;消化道溃疡;临床效果分析

    [中图分类号] R573.1 [文献标识码] A [文章编号] 1674-0742(2017)08(b)-0150-03

    Clinical Study of Lansoprazole Combined with Kangfuxin Liquid in Treatment of Peptic Ulcer

    XU Li

    Hi-tech Zhonghe Community Health Service Center, Chengdu, Sichuan Province, 610212 China

    [Abstracts] Objective This paper tries to analyze the effect of lansoprazole combined with kangfuxin liquid in treatment of patients with peptic ulcer. Methods 150 patients with peptic ulcer diagnosed in this hospital from January 2016 to January 2017 were conveniently selected and randomly divided into two groups, the control group was treated with Lansoprazole capsules for 2 weeks, the combined group added kangfuxin liquid. The curative effect, hemostatic time, and gastric juice pH value and serum gastrin level of the two groups were compared and analyzed. Results The total effective rate of the combined group was 94.66%, which was better than that of the control group of 69.34%. The combined group had high pH value, low serum gastrin level and shorter hemostasis time than the control group, the difference was statistically significant (P<0.05). Conclusion For patients with peptic ulcer, the clinical effect of lansoprazole combined with kangfuxin liquid is better, can improve the pH value of gastric juice, whose effect is ideal and is worth clinical promotion.

    [Key words] Lansoprazole; Kangfuxin liquid; Peptic ulcer; Clinical effect analysis

    临床出现周期性、慢性、规律性的上腹部疼痛、嗳气、反酸、恶心、烧灼感为主要症状的消化系统疾病,胃部与十二指肠部常见,极易反复发生的称为消化道溃疡,严重时可发生出血和穿孔[1]。目前,全球约有10%人口患有过消化性溃疡,此病发病率高,给人民的日常生活及工作带来了极大的困扰[2]。因此,找到一种防止病情扩大降低复发的方法为消化性溃疡治疗的关键。该院采用兰索拉唑联合康复新液治疗从2016年1月—2017年1月收治的75例消化道溃疡患者,取得了较好的治疗效果,现报道如下。

    1 资料与方法

    1.1 一般资料

    方便选取该院诊治消化道溃疡患者150例,纳入标准[3]:年龄介于18~65岁之间;胃镜下活检确定诊断为消化道溃疡表面直径为0.3~2.0 cm;为首次确诊者或近1月内未接受过治疗。排除标准[4]:年龄<18岁或>65岁;溃疡表面过大,或者复合性溃疡;对该研究中使用药物过敏;哺乳或妊娠期妇女;近1个月内口服或静脉滴注过抗生素;伴有严重器官功能不全;拒不配合治疗或者回访患者。联合组75例,男41例(54.67%),女34例(45.33%),年龄23~69岁,平均(42.1±3.1)岁,胃溃疡39例,十二指肠溃瘍36例。对照组75例,男43例(57.33%),女32例(42.67%),年龄28~68岁,平均(40.6±3.2)岁,胃溃疡40例,十二指肠溃疡35例。在年龄、性别比对,差异无统计学意义(P>0.05),有可比性。

    1.2 治疗方法

    入院后立即完善相关检查,均采用止血、保护胃黏膜等常规治疗方式。对照组:兰索拉唑胶囊(国药准字H20084570,规格:15 mg)30 mg 1次/d餐前口服治疗2周。联合组在其基础上+康复新液(国药准字Z51021834)10 mL/次,3次/d餐前口服治疗2周。, http://www.100md.com(徐莉)
1 2下一页